BI Asset Management Fondsmaeglerselskab A S Sells 82,035 Shares of Walgreens Boots Alliance, Inc. $WBA

Key Points

• BI Asset Management Fondsmaeglerselskab A S sold 82,035 shares of Walgreens Boots Alliance, reducing its holdings by 80.9% to 19,380 shares, valued at $216,000.
• Several hedge funds, including Curat Global LLC and Sentry Investment Management LLC, also initiated new positions in Walgreens Boots Alliance during the same quarter.
• Walgreens Boots Alliance reported a 7.2% year-over-year revenue increase with an EPS of $0.38, surpassing estimates and reflecting a negative net margin of 4.07%.

BI Asset Management Fondsmaeglerselskab A S lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 80.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,380 shares of the pharmacy operator's stock after selling 82,035 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in Walgreens Boots Alliance were worth $216,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Curat Global LLC purchased a new stake in Walgreens Boots Alliance in the first quarter valued at approximately $27,000. Sentry Investment Management LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter worth approximately $27,000. Colonial Trust Co SC increased its holdings in shares of Walgreens Boots Alliance by 79.5% in the 4th quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,297 shares during the last quarter. Federated Hermes Inc. raised its position in shares of Walgreens Boots Alliance by 135.8% during the 1st quarter. Federated Hermes Inc. now owns 3,152 shares of the pharmacy operator's stock valued at $35,000 after buying an additional 1,815 shares in the last quarter. Finally, N.E.W. Advisory Services LLC bought a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth $43,000. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock opened at $12.07 on Friday. The stock has a market capitalization of $10.45 billion, a P/E ratio of -1.66, a price-to-earnings-growth ratio of 1.42 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $13.25. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The business's 50 day simple moving average is $11.63 and its two-hundred day simple moving average is $11.18.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Thursday, June 26th. The pharmacy operator reported $0.38 EPS for the quarter, topping the consensus estimate of $0.34 by $0.04. The company had revenue of $38.99 billion for the quarter, compared to the consensus estimate of $36.72 billion. Walgreens Boots Alliance had a negative net margin of 4.07% and a positive return on equity of 17.66%. The firm's revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.63 earnings per share. Analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently commented on WBA. UBS Group reissued a "neutral" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Wall Street Zen initiated coverage on Walgreens Boots Alliance in a report on Wednesday, May 21st. They set a "hold" rating on the stock. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Two equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Reduce" and an average price target of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.